| Date Filed | Type | Description |
| 07/05/2023 |
4
| Cawkwell Gail (Chief Medical Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,407 shares
@ $10.37, valued at
$56.1k
Exercised 15,000 restricted stock units
@ $0 |
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/15/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 320 shares
@ $15.8, valued at
$5.1k
|
|
| 01/31/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 6,600 shares
@ $0
Granted 11,300 options to buy
@ $14.44, valued at
$163.2k
|
|
| 01/04/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 2,455 shares
@ $16.29, valued at
$40k
|
|
| 11/16/2021 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $19.04, valued at
$6.1k
|
|
| 05/13/2021 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $17.75, valued at
$5.7k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $38.52, valued at
$12.3k
|
|
| 08/14/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $53.44, valued at
$17k
|
|
| 05/14/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $89.05, valued at
$28.4k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,200 shares
@ $0
Granted 6,900 options to buy
@ $99.66, valued at
$687.7k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Exercised 80 options to buy
@ $54.63, valued at
$4.4k
|
|
| 11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 319 shares
@ $86.66, valued at
$27.6k
|
|
| 04/22/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,750 options to buy
@ $54.63, valued at
$95.6k
|
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,100 shares
@ $0
Granted 6,700 options to buy
@ $110.8, valued at
$742.4k
|
|
| 12/14/2018 |
3
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 3 on INTERCEPT PHARMACEUTICALS, INC. |